throbber
Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 1 of 8
`
`Exhibit A
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 2 of 8
`
`21-—2-00711-29
`CMP
`2
`HAL
`a0

`eb AE
`Complaint
`SKAGIT COUETY, 84
`11484637
`OU
`MUINEC ~2 PH 218
`
`
`
`
`SUPERIOR COURT OF THE STATE OF WASHINGTON
`IN AND FOR SKAGIT COUNTY
`
`Cause Number:
`ul Z 00] |
`:
`.
`
`| 24
`_
`
`COMPLAINT
`
`EILEEN HOLLAND,
`
`Plaintiff,
`
`Vv.
`
`ACELLA PHARMACEUTICALS, LLC;
`
`SAFEWAY,INC., d/b/a: HAGGEN #3436;
`
`HH LEGACY,INC., d/b/a: HAGGEN FOOD
`& PHARMACY#15; and
`
`DOE 1 — DOE 25.
`
`Defendants.
`
`
`I.
`
`INTRODUCTION
`
`1. Buyer beware is not the law in the State of Washington.
`
`2. To lawfully sell pharmaceutical drugs to consumers in Washington, the drugs must
`
`conform to national pharmaceutical standards for strength, quality, and purity.
`
`3. For pharmaceutical drugs to conform to compendial standards of strength, quality, and
`
`1 2 3 4 5 6 7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19||
`
`20
`
`21
`
`~]
`
`purity, laboratory controls must be scientifically sound and designed to assure that
`22
`
`COMPLAINT
`SULLIVAN LAW GROUP, PLLC
`PAGE I
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 322-1076 ~ Fax: (425) 609-3760a
`
`A sa!
`
`AMaree thi
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 3of8
`
`components, materials, labeling, and the actual drugs conform to standards.
`
`Acella Pharmaceuticals, LLC failed to conform to these standards, and sold Acella NP
`
`Thyroid® tablets that had excessive amounts of Liothyronine (T3), a man-made form
`
`of thyroid hormone.
`
`A Haggen grocery store in Burlington, Washington purchased the defective Acella NP
`
`Thyroid® tablets and re-sold them to Eileen Holland.
`
`Eileen Holland took the NP THYROID®asordered by her doctor.
`
`Asdirected in the Acella Pharmaceuticals NP Thyroid® Important Safety Information
`
`Sheet, Eileen did not stop or change the amount she took, or how often she took it, until
`
`eventually told to do so by her medical provider.
`
`This was unfortunately not until after Eileen had suffered effects of excessive
`
`Liothyronine which resulted in her physical and emotional injuries which shall be
`
`provedattrial.
`
`Il.
`
`PARTIES
`
`Acella Pharmaceuticals, LLC is pharmaceutical company in Forsyth County, Georgia.
`
`10.
`
`Safeway, Inc. owns the Haggen grocery store in Burlington, Washington (Haggen
`
`#3436) where Eileen purchased the defective Acella NP Thyroid® tablets.
`
`11.
`
`Aspart of Safeway Inc.’s businessit either operates or leases space to other pharmacies
`
`at someofits stores; that is the case with Haggen #3436.
`
`12.
`
`HH Legacy, Inc., does business as Haggen Food & Pharmacy #15, and operates the
`
`pharmacy at Haggen #3436.
`
`13.
`
`Safeway, Inc.; Haggen #3436; HH Legacy,Inc.; and Haggen Food & Pharmacy #15 are
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`
`
`COMPLAINT
`PAGE 2
`
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 322-1076 - Fax: (425) 609-3760
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 4of8
`
`hereinafter collectively referred to as “Safeway.”
`
`14.
`
`Doe | through Doe 25 are persons or business who were involved in the manufacture,
`
`oversight, or transaction of defective Acella NP Thyroid® tablets.
`
`I.
`
`JURISDICTION AND VENUE
`
`15.
`
`The Court has personal jurisdiction overall the parties.
`
`16.
`
`Venueis appropriate in Skagit County Superior Court, where the defective product was
`
`sold to Eileen Holland.
`
`Iv.
`
`FACTS
`
`17.
`
`Acella Pharmaceuticals, LLC claimsthat its NP Thyroid® tablets are, “Made with the
`
`highest quality standards under cGMP,” which is the Current Good Manufacturing
`
`Practices for drugs, per Section 21 of the US Code of Federal Regulations
`
`Parts 210 and 211.!
`
`18.
`
`Acella Pharmaceuticals, LLC claimsthat its NP Thyroid® tablets are subject to Batch-
`
`to-batch testing to ensure consistent T4 & T3.””
`
`19.
`
`Regardless of these claims, Acella Pharmaceuticals, LLC failed to conform to Current
`
`Good Manufacturing Practices for drugs and sold Acella NP Thyroid® tablets that had
`
`excessive amounts of Liothyronine (T3), a man-made form of thyroid hormone.
`
`20.
`
`The risk and cost of injuries when pharmaceuticals do not conform to Current Good
`
`Manufacturing Practices for drugs substantially outweighs the cost
`
`for Acella
`
`Pharmaceuticals, LLC to make pharmaceuticals that are within standards.
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`' https://npthyroid.com/about/
`? https://npthyroid.com/about/
`
`
`COMPLAINT
`PAGE 3
`
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 322-1076 - Fax: (425) 609-3760
`
`

`

`
`
`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page5of8
`
`21.
`
`Ordinary consumers would not be aware that their pharmaceutical drugs contain up to
`
`115% ofthe labeled amountof active ingredient without conducting testing that is cost-
`prohibitive to the ordinary consumer.
`.
`
`22.
`
`Consumers do not and would not recognize hormone drugs as safe when they contain
`
`up to 115% of the labeled amount of an active ingredient, as was the case with the
`
`defective Acella NP Thyroid® tablets.
`
`23.
`
`Acella’s NP Thyroid® tablets did not contain adequate warnings or instructions,
`
`including that the drug as actually manufactured may not be FDA approved, nor being
`
`sold with a valid biologics license.’
`
`24.
`
`Acella Pharmaceuticals LLC’s sale of its defective NP Thyroid® tablets breached
`
`warranties both express and implied.
`
`25.
`
`On May 22, 2020, the FDA published Acella Pharmaceuticals LLC recall of 30-mg NP
`Thyroid® tablets based on a warning of super potency and the receipt of at least two
`
`adverse events knownto berelated to the recall.
`
`26.
`
`Nonetheless, on June 13, 2020, the Safeway defendants sold Eileen 30-mg NP Thyroid®
`
`tablets from the recalled lot of defective drugs.
`
`27.
`
`The defective NP Thyroid® tablets purchased by Eileen were a direct and proximate
`
`cause of her injuries that will be provenattrial.
`
`28.
`
`Doe 1
`
`through Doe 25 have not yet been identified, but were involved in the
`
`manufacture, oversight, or transaction of defective Acella NP Thyroid® tablets.
`
`Hf
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`3 See https://www.fda.gov/inspections-compliance-enforcement-and-criminal-
`investigations/warning-letters/acella-pharmaceuticals-llc-604438-08 142020
`
`
`COMPLAINT
`PAGE 4
`
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 322-1076 - Fax: (425) 609-3760
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 6 of8
`
`V.
`
`CLAIM FOR DAMAGES UNDER THE
`WASHINGTON PRODUCTLIABILITY ACT
`
`29. PlaintiffEileen Holland restates and reincorporates each ofthe preceding paragraphs.
`30. Defendant Acella Pharmaceuticals, LLC manufactured and supplied a product that was
`not reasonably safe in construction at the time the productleft its control because it did
`not conform to the manufacturer's express warranty.
`31. Defendant AcellaPharmaceuticals, LLC supplied aproduct thatwas not reasonably safe
`in construction at the time the productleft its control because it did not conform to its
`design.
`
`32. Defendant Acella Pharmaceuticals, LLC supplied a product that was not reasonably safe
`
`in construction at the time the productleft its control because it did not have adequate
`warnings
`
`33. The defective pharmaceuticals sold to Eileen Holland were the direct and proximate
`
`cause ofher injuries and damages.
`34. The collective Safeway defendants were negligent in selling Eileen Holland a recalled
`drug that wasrecalled for its super potency.
`35. Noneofthe collective Safeway defendants warned Eileen Holland that the drugsit sold
`her had beenrecalled for super potency.
`VI.
`CLAIM FOR DAMAGES UNDER THE CONSUMER PROTECTION ACT
`36. PlaintiffEileen Holland restates and reincorporates each ofthe preceding paragraphs.
`37. It was deceptive or unfair for Acella Pharmaceuticals, LLC to advertise that its drugs
`
`1
`
`;




`'
`.
`
`9
`
`.
`"
`
`12
`
`s
`"


`0
`"

`*
`
`21
`
`were made under the “highest quality standards under cGMP,” when the drugs as
`
`
`
`COMPLAINT
`PAGE 5
`
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 822-1076 - Fax: (425) 609-3760
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 7 of8
`
`manufactured did not conform to design.
`
`38.
`
`It was deceptive and unfair for the Safeway defendants to sell pharmaceutical drugs that
`
`were subject to an outstanding drug recall without notifying the buyer before purchase.
`The deceptive and unfair acts of Acella Pharmaceuticals, LLC and the Safeway
`
`39.
`
`defendants injured Eileen in her property: the money she spent on drugs that had been
`
`recalled.
`
`40.
`
`The deceptive and unfair acts of Acella Pharmaceuticals, LLC and the Safeway
`
`defendants caused Eileen’s injury because she would not have taken the drugs but for
`
`the deceptive and unfair acts of the defendants.
`
`Vil.
`
`CLAIM FOR DAMAGES FROM NEGLIGENCE
`
`41.
`
`Plaintiff Eileen Holland restates and reincorporates each of the preceding paragraphs.
`
`42.
`
`The Safeway defendants were negligentin selling drugs that were subject to FDArecall.
`
`43.
`
`The Safeway defendants were negligentfor failing to tell Eileen that the drugs they were
`
`selling her were subject to FDArecall.
`
`44.
`
`The negligence of the Safeway defendants caused Eileen’s injuries and damages
`
`because she would not have taken the drugs but for them selling them to her.
`
`VU.
`
`PRAYER FOR RELIEF
`
`45,
`
`Wherefore, Plaintiff prays for judgment as follows:
`
`46.
`
`For her economic losses that were caused by the related injuries;
`
`47.
`
`For her non-economic losses that were causedbythe related injuries;
`
`48.
`
`For attorney fees and costs, as determined by the Court;
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`For jury consideration of trebling damages;
`49.
`
`COMPLAINT
`SULLIVAN LAW GROUP, PLLC
`PAGE6
`2932 Hoyt Avenue, Everett WA 98201°
`Tel: (425) 322-1076 - Fax: (425) 609-3760
`
`

`

`Case 2:22-cv-00002 Document 1-1 Filed 01/03/22 Page 8 of8
`
`50. For exemplary and/or punitive damagesas authorized bythe lawsofthe State of
`
`Georgia
`
`51. For any otherrelief the Court believes ifjust and appropriate.
`
`Dated this 30" day of November 2021.
`
`By:_/s/ Brian M. Sullivan
`Brian M.Sullivan, WSBA #38066
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue
`Everett, WA 98201
`Tel: 425.322.1076
`Fax: 425.609.3760
`brian@sullivanpllc.com
`
`1
`
`2
`
`3
`
`4]
`
`5
`
`6
`
`7
`
`8
`
`9
`
`Attorneyfor PlaintiffEileen Holland
`
`COMPLAINT
`PAGE 7
`
`SULLIVAN LAW GROUP, PLLC
`2932 Hoyt Avenue, Everett WA 98201
`Tel: (425) 322-1076 - Fax: (425) 609-3760
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket